华东医药(000963.SZ)：含利多卡因注射用交联透明质酸钠凝胶注册申请获受理

Core Viewpoint - The company Huadong Medicine (000963.SZ) announced that its wholly-owned subsidiary, Xinkelimeixue (Hangzhou) Medical Technology Co., Ltd., has received an acceptance notice from the National Medical Products Administration (NMPA) for its Class III medical device registration application for the lidocaine injection cross-linked transparent hyaluronic acid gel MaiLi Precise [1] Group 1 - Huadong Medicine's subsidiary has successfully submitted a registration application for a new medical device [1] - The acceptance of the application indicates progress in the company's product development pipeline [1] - The product in question is a Class III medical device, which typically requires rigorous regulatory scrutiny [1]